Population
Preclinical model (myocardium and soleus muscle) of isoproterenol-induced myotoxicity
Design
Preclinical
Authors
Loading...
May enable beta-AR subtype-specific bioassays in HF models; leaves open human translation and clinical relevance.
The differential mediation of catecholamine-induced myotoxicity by beta1 and beta2 adrenoceptors in cardiac and skeletal muscle provides a potential new bioassay for evaluating beta-blockers in heart failure.
Tan et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: